Patent · US Active

N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

US10214533B2 · kind B2 · utility

0Cited by
5References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2018
Grant dateFeb 26, 2019
Priority date—
Expiry dateApr 18, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel compounds of Formula I and their use in therapeutic treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.